DEODATO GALLERY SPA (ART.MI) Stock Fundamental Analysis

BIT:ART • IT0005528937

0.232 EUR
-0.02 (-8.66%)
Last: Feb 10, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ART. ART was compared to 61 industry peers in the Hotels, Restaurants & Leisure industry. While ART seems to be doing ok healthwise, there are quite some concerns on its profitability. ART is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ART has reported negative net income.
  • ART had a positive operating cash flow in the past year.
ART.MI Yearly Net Income VS EBIT VS OCF VS FCFART.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

  • ART has a Return On Assets of 1.05%. This is in the lower half of the industry: ART underperforms 62.30% of its industry peers.
  • ART has a Return On Equity (2.35%) which is comparable to the rest of the industry.
  • ART has a worse Return On Invested Capital (3.16%) than 63.93% of its industry peers.
  • ART had an Average Return On Invested Capital over the past 3 years of 13.79%. This is in line with the industry average of 11.93%.
  • The last Return On Invested Capital (3.16%) for ART is well below the 3 year average (13.79%), which needs to be investigated, but indicates that ART had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROIC 3.16%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ART.MI Yearly ROA, ROE, ROICART.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60

1.3 Margins

  • ART's Profit Margin of 1.24% is on the low side compared to the rest of the industry. ART is outperformed by 63.93% of its industry peers.
  • ART's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ART (2.74%) is worse than 67.21% of its industry peers.
  • ART's Operating Margin has declined in the last couple of years.
  • The Gross Margin of ART (25.49%) is comparable to the rest of the industry.
  • ART's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
ART.MI Yearly Profit, Operating, Gross MarginsART.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ART is creating value.
  • ART has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ART is higher compared to a year ago.
ART.MI Yearly Shares OutstandingART.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ART.MI Yearly Total Debt VS Total AssetsART.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • ART has an Altman-Z score of 2.50. This is not the best score and indicates that ART is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ART (2.50) is better than 67.21% of its industry peers.
  • ART has a debt to FCF ratio of 12.11. This is a negative value and a sign of low solvency as ART would need 12.11 years to pay back of all of its debts.
  • ART's Debt to FCF ratio of 12.11 is on the low side compared to the rest of the industry. ART is outperformed by 62.30% of its industry peers.
  • A Debt/Equity ratio of 0.12 indicates that ART is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.12, ART belongs to the top of the industry, outperforming 83.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Altman-Z 2.5
ROIC/WACC0.44
WACC7.26%
ART.MI Yearly LT Debt VS Equity VS FCFART.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M -2M 4M

2.3 Liquidity

  • ART has a Current Ratio of 1.96. This is a normal value and indicates that ART is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ART (1.96) is better than 98.36% of its industry peers.
  • A Quick Ratio of 1.06 indicates that ART should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.06, ART is in the better half of the industry, outperforming 70.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.06
ART.MI Yearly Current Assets VS Current LiabilitesART.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M

3

3. Growth

3.1 Past

  • ART shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 400.00%, which is quite impressive.
  • ART shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -50.75% yearly.
  • The Revenue for ART has decreased by -14.67% in the past year. This is quite bad
  • The Revenue has been growing by 14.70% on average over the past years. This is quite good.
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.MI Yearly Revenue VS EstimatesART.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.MI Price Earnings VS Forward Price EarningsART.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • ART's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, ART is valued a bit more expensive than the industry average as 67.21% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 42.71
EV/EBITDA 12.41
ART.MI Per share dataART.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.05 0.1 0.15 0.2 0.25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ART!.
Industry RankSector Rank
Dividend Yield 0%

DEODATO GALLERY SPA

BIT:ART (2/10/2026, 7:00:00 PM)

0.232

-0.02 (-8.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.11%
Inst Owner ChangeN/A
Ins Owners83.3%
Ins Owner ChangeN/A
Market Cap7.27M
Revenue(TTM)8.87M
Net Income(TTM)109.60K
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.82
P/FCF 42.71
P/OCF 20.63
P/B 1.56
P/tB 1.96
EV/EBITDA 12.41
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY2.34%
OCF(TTM)0.01
OCFY4.85%
SpS0.28
BVpS0.15
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.05%
ROE 2.35%
ROCE 4.21%
ROIC 3.16%
ROICexc 4.55%
ROICexgc 5.99%
OM 2.74%
PM (TTM) 1.24%
GM 25.49%
FCFM 1.92%
ROA(3y)6.18%
ROA(5y)N/A
ROE(3y)16.81%
ROE(5y)N/A
ROIC(3y)13.79%
ROIC(5y)N/A
ROICexc(3y)18.08%
ROICexc(5y)N/A
ROICexgc(3y)22.97%
ROICexgc(5y)N/A
ROCE(3y)18.39%
ROCE(5y)N/A
ROICexgc growth 3Y-56.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-59.09%
ROICexc growth 5YN/A
OM growth 3Y-50.63%
OM growth 5YN/A
PM growth 3Y-57.05%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 12.11
Debt/EBITDA 0.95
Cap/Depr 50.07%
Cap/Sales 2.05%
Interest Coverage 250
Cash Conversion 58.02%
Profit Quality 155.29%
Current Ratio 1.96
Quick Ratio 1.06
Altman-Z 2.5
F-Score7
WACC7.26%
ROIC/WACC0.44
Cap/Depr(3y)231.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)400%
EPS 3Y-50.75%
EPS 5YN/A
EPS Q2Q%81.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.67%
Revenue growth 3Y14.7%
Revenue growth 5YN/A
Sales Q2Q%-23.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y76.45%
EBIT growth 3Y-43.38%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y107.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.72%
OCF growth 3YN/A
OCF growth 5YN/A

DEODATO GALLERY SPA / ART.MI FAQ

What is the ChartMill fundamental rating of DEODATO GALLERY SPA (ART.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ART.MI.


What is the valuation status for ART stock?

ChartMill assigns a valuation rating of 0 / 10 to DEODATO GALLERY SPA (ART.MI). This can be considered as Overvalued.


How profitable is DEODATO GALLERY SPA (ART.MI) stock?

DEODATO GALLERY SPA (ART.MI) has a profitability rating of 2 / 10.


Can you provide the financial health for ART stock?

The financial health rating of DEODATO GALLERY SPA (ART.MI) is 5 / 10.